EUVIMEDEUVIMED entdecken
Open Access

The Development of Cancer through the Transient Overexpression of Reprogramming Factors

Chika Miyagi-Shiohira, Yoshiki Nakashima, Naoya Kobayashi, Issei Saitoh, Masami Watanabe, Yasufumi Noguchi, Takao Kinjo, Hirofumi Noguchi

Cell Medicine · 2018

DOI: 10.1177/2155179017733172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Medicine, 2018. Verfasst von Chika Miyagi-Shiohira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although induced pluripotent stem (iPS) cells have significant implications for overcoming most of the ethical issues associated with embryonic stem cells, several issues related to the use of iPS cells in clinical applications remain unresolved, including the issue of teratoma formation. We previously reported that the induction of induced tissue-specific stem (iTS) cells from the pancreas (iTS-P) or liver (iTS-L) by the transient overexpression of reprogramming factors, combined with tissue-specific selection and the generation of iTS cells, could have important implications for the clinical application of stem cells. At the same time, we also generated “induced fibroblast-like (iF) cells” that were capable of self-renewal, which had a similar morphology to fibroblast cells. In this study, we evaluated iF cells. iF cells are unlikely to show adipogenic/osteogenic differentiation. Moreover, iF cells have the ability to form tumors and behave similarly to pancreatic cancer cells. The technology used in the generation of iPS/iTS cells is also associated with the risk of generating cancer-like cells.

Schlagwörter

Stichwörter der Autor:innen

induced fibroblast-like (iF) cellsinduced pluripotent stem (iPS) cellsinduced tissue-specific stem (iTS) cellspancreatic cancerreprogramming factors

Autor:innen und Institutionen

  • Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Okayama Saidaiji Hospital, Okayama, Japan.
  • Division of Pediatric Dentistry, Graduate School of Medical and Dental Science, Niigata University, Niigata, Japan.
  • Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Socio-environmental Design, Hiroshima International University, Hiroshima, Japan.
  • Department of Basic Laboratory Sciences, Division of Morphological Pathology, School of Health Sciences, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.

Zitieren

APA

Miyagi-Shiohira, C., Nakashima, Y., Kobayashi, N., Saitoh, I., Watanabe, M., Noguchi, Y., Kinjo, T., & Noguchi, H. (2018). The Development of Cancer through the Transient Overexpression of Reprogramming Factors. Cell Medicine. https://doi.org/10.1177/2155179017733172

Vancouver

Miyagi-Shiohira C, Nakashima Y, Kobayashi N, Saitoh I, Watanabe M, Noguchi Y, et al. The Development of Cancer through the Transient Overexpression of Reprogramming Factors. Cell Medicine. 2018. doi:10.1177/2155179017733172

BibTeX
@article{MiyagiShiohira2018,
  author = {Miyagi-Shiohira, Chika and Nakashima, Yoshiki and Kobayashi, Naoya and Saitoh, Issei and Watanabe, Masami and Noguchi, Yasufumi and Kinjo, Takao and Noguchi, Hirofumi},
  title = {The Development of Cancer through the Transient Overexpression of Reprogramming Factors},
  journal = {Cell Medicine},
  year = {2018},
  doi = {10.1177/2155179017733172}
}
Kostenlos starten →